/
Background Ascend Wellness Holdings, Inc. is a vertically integrated multi-state cannabis operator focused on operating in adult-use or near-term adult-use states in primarily limited license markets. Ascend s core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which are sold through company-owned retail stores, to retail partner locations, and…
$0.45
+$0.04 (+9.76%)
EOD Jul 17, 2026
The business is unprofitable at the operating level (-3.40% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 10.9% YoY. Margins deteriorated 4.2pp alongside, both lines moving the wrong way.
Free cash flow declined 76% versus the prior year, cash generation momentum has weakened. ROIC dropped from 0.55% to -2.16%, capital efficiency is deteriorating.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$490M
▼ -10.9% YoY
Net Income (TTM)
-$128M
▼ -39.1% YoY
Op. Margin
-3.46%
▼ -4.2pp YoY
ROIC
-2.11%
▼ -2.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$12M
▼ -76.3% YoY
Op. Cash Flow (TTM)
$13M
▼ -48.1% YoY
Net Debt
$552M
Cash & Equiv.
$61M
5Y CAGR: +28.3%
Continue Research
Ascend Wellness Holdings (AAWH)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Ascend Wellness Holdings scores 11/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Ascend Wellness Holdings scores 11 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -3.5% operating margin and a -2.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh AAWH's valuation and scores 11/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.